Author

Tom J.J. Schirris

University of CambridgeORCID 0000-0002-3364-0069Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:protein structure· 1

Frequent Co-Authors

Chancievan ThangaratnarajahiD· 1 shared Daniel T.D. JonesiD· 1 shared Edmund R.S. KunjiiD· 1 shared Ian M. FearnleyiD· 1 shared Martin S. KingiD· 1 shared Shujing Ding· 1 shared Sotiria TavoulariiD· 1 shared Vasiliki MavridouiD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Chancievan ThangaratnarajahORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Key features of inhibitor binding to the human mitochondrial pyruvate carrier hetero-dimer

Sotiria Tavoulari, Tom J.J. Schirris, Vasiliki Mavridou, Chancievan Thangaratnarajah, Martin S. King, Daniel T.D. Jones, Shujing Ding, Ian M. Fearnley, Edmund R.S. Kunji

The paper identifies key chemical features of inhibitors binding to the human mitochondrial pyruvate carrier hetero-dimer and discovers new inhibitors with higher potency than existing ones.

Molecular Metabolism · Mar 9, 2022Peer-reviewedMolecular Biology